|
Which RhD alleles are risk factors stimulating allo- anti-D? |
|
View Full Text View/Add Comment Download reader |
DOI:10.46701/APJBG.2017032017043 |
KeyWord:RhD-negative, anti-D, alloimmunization, partial D, Del |
Author | Institution |
Fang Yan |
Blood Group Lab, Beijing Red Cross Blood Center, Beijing, 100088, China |
Yu-Shiang Lin |
Department of Clinical Medicine, School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China;
College of Medicine. Aerospace Center Hospital, Beijing, 100076, China. |
Zhiyuan Xu |
Blood Group Lab, Beijing Red Cross Blood Center, Beijing, 100088, China |
Xiaofei Li |
Blood Group Lab, Beijing Red Cross Blood Center, Beijing, 100088, China |
Lei Zhang |
Blood Group Lab, Beijing Red Cross Blood Center, Beijing, 100088, China |
Ye Zhang |
Blood Group Lab, Beijing Red Cross Blood Center, Beijing, 100088, China |
SuFang Liu |
Blood Group Lab, Beijing Red Cross Blood Center, Beijing, 100088, China |
TianHong Miao |
Blood Group Lab, Beijing Red Cross Blood Center, Beijing, 100088, China |
|
Hits: 2468 |
Download times: 2255 |
Abstract: |
The aim of this study was to identify the specific RhD alleles that are risk factors for stimulating allo-anti-D and develop a precise strategy for blood transfusion. To confirm the D phenotype, red blood cells suspended in saline should react to serological anti-D from three manufacturers. An antibody screen test, a saline phase test and a micro-column test were conducted to identify allo-anti-D and other allo-antibodies. RhD alleles were genotyped by PCR using sequence-specific primers. Seven hundred subjects who were either pregnant or had undergone transfusion were enrolled in our study; however, 28 samples were excluded because their RhD alleles were normal, as revealed by tests using genotyping kits. A total of 498 cases (74.1%) were RhD-null (lacking exons 1–10 of RhD), 336 were DEL RhD 1227A (20.2%), and 38 were RHD-CE (2-9) -D (5.6%). There were 136 cases (20.2%) with allo-anti-D among the 672 cases, with an allo-anti-D prevalence of 126 cases (25.3%) in 498 cases that were RhD-null, followed by 10 cases (26.3%) among 38 cases with RHD-CE (2-9) -D, and none in 366 cases with RhD1227A. RhD genetic polymorphism was observed in RhD-negative individuals. We concluded that RhD-null and partial D are risk factors for alloimmunization to the D antigen and should be transfused with Rh-negative blood. RHD1227A recipients can be transfused with RhD-positive blood. Pregnant women with the d/d and D-CE(2-9)-D alleles require appropriate anti-D prophylaxis and RhD1227A may induce a higher tolerance. |
Close |
|
|
|